# Danyuan Medical Technology (Hangzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/danyuan-medical-technology-hangzhou-co

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Latest round: Series A (Feb 26, 2026)
- Investors on record: 1

## About

Based in Hangzhou, China and founded in 2018, Danyuan Medical Technology (Hangzhou) Co., Ltd. is a high-tech enterprise specializing in the R&D of cardiac rhythm management medical devices. In February 2026, Danyuan Medical Technology (Hangzhou) Co., Ltd. raised a series A+ funding from Tsing Song Capital.

The company is committed to providing implantable medical devices for cardiovascular disease patients, with products covering pacemakers, cardiac resynchronization therapy (CRT) systems, and various electrode leads. 

The company's revenue is generated by implantable medical devices for cardiovascular disease patients, with products covering pacemakers, cardiac resynchronization therapy (CRT) systems, and various electrode leads. 

The company will use the funding to expand its R&D, production, and sales of cardiac rhythm management-related products such as implantable pacemakers, CRTs, and electrode leads.

## Funding rounds

- Series A, Feb 26, 2026 — Tsing Song Capital

## Investors

- Tsing Song Capital (https://capitalatlas.ai/funds/tsing-song-capital) — Series A